Cargando…
A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment
Pancreatic neuroendocrine tumors (PanNETs) are a rare subtype of pancreatic cancer and can be divided into functional (30–40%) and nonfunctional subtypes. The different subtypes of functional PanNETs (F-PanNETs) have a variety of classical presentations that raise suspicion for an underlying PanNET....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659674/ https://www.ncbi.nlm.nih.gov/pubmed/37986400 http://dx.doi.org/10.1097/MD.0000000000036094 |
_version_ | 1785148362782146560 |
---|---|
author | Alshareefy, Yasir Cummins, Sinead Mazzoleni, Adele Sharma, Vidushi Guggilapu, Saibaba Leong, Amanda Weng Yee Wireko, Andrew Awuah |
author_facet | Alshareefy, Yasir Cummins, Sinead Mazzoleni, Adele Sharma, Vidushi Guggilapu, Saibaba Leong, Amanda Weng Yee Wireko, Andrew Awuah |
author_sort | Alshareefy, Yasir |
collection | PubMed |
description | Pancreatic neuroendocrine tumors (PanNETs) are a rare subtype of pancreatic cancer and can be divided into functional (30–40%) and nonfunctional subtypes. The different subtypes of functional PanNETs (F-PanNETs) have a variety of classical presentations that raise suspicion for an underlying PanNET. It is estimated that 90% of PanNETs are sporadic, and the PI3K-Akt-mTOR and ATRX/DAXX signaling pathways have been recognized as key genetic pathways implicated in the pathogenesis. The other 10% of PanNETs may occur in the context of familial cancer syndromes such as MEN1. Chromogranin A is the most useful biomarker currently; however, several studies have shown limitations with its use, especially its prognostic value. Synaptophysin is a novel biomarker which has shown promising preliminary results however its use clinically has yet to be established. Blood tests assessing hormone levels, cross-sectional imaging, and endoscopic ultrasound remain at the core of establishing a diagnosis of F-PanNET. The treatment options for F-PanNETs include surgical methods such as enucleation, systemic therapies like chemotherapy and novel targeted therapies such as everolimus. The prognosis for F-PanNETs is more favorable than for nonfunctional PanNETs, however metastatic disease is associated with poor survival outcomes. Researchers should also focus their efforts on identifying novel pathways implicated in the pathogenesis of F-PanNETs in order to develop new targeted therapies that may reduce the need for surgical intervention and on the establishment of novel biomarkers that may reduce the need for invasive testing and allow for earlier detection of F-PanNETs. |
format | Online Article Text |
id | pubmed-10659674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106596742023-11-17 A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment Alshareefy, Yasir Cummins, Sinead Mazzoleni, Adele Sharma, Vidushi Guggilapu, Saibaba Leong, Amanda Weng Yee Wireko, Andrew Awuah Medicine (Baltimore) 4500 Pancreatic neuroendocrine tumors (PanNETs) are a rare subtype of pancreatic cancer and can be divided into functional (30–40%) and nonfunctional subtypes. The different subtypes of functional PanNETs (F-PanNETs) have a variety of classical presentations that raise suspicion for an underlying PanNET. It is estimated that 90% of PanNETs are sporadic, and the PI3K-Akt-mTOR and ATRX/DAXX signaling pathways have been recognized as key genetic pathways implicated in the pathogenesis. The other 10% of PanNETs may occur in the context of familial cancer syndromes such as MEN1. Chromogranin A is the most useful biomarker currently; however, several studies have shown limitations with its use, especially its prognostic value. Synaptophysin is a novel biomarker which has shown promising preliminary results however its use clinically has yet to be established. Blood tests assessing hormone levels, cross-sectional imaging, and endoscopic ultrasound remain at the core of establishing a diagnosis of F-PanNET. The treatment options for F-PanNETs include surgical methods such as enucleation, systemic therapies like chemotherapy and novel targeted therapies such as everolimus. The prognosis for F-PanNETs is more favorable than for nonfunctional PanNETs, however metastatic disease is associated with poor survival outcomes. Researchers should also focus their efforts on identifying novel pathways implicated in the pathogenesis of F-PanNETs in order to develop new targeted therapies that may reduce the need for surgical intervention and on the establishment of novel biomarkers that may reduce the need for invasive testing and allow for earlier detection of F-PanNETs. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659674/ /pubmed/37986400 http://dx.doi.org/10.1097/MD.0000000000036094 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 4500 Alshareefy, Yasir Cummins, Sinead Mazzoleni, Adele Sharma, Vidushi Guggilapu, Saibaba Leong, Amanda Weng Yee Wireko, Andrew Awuah A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title | A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title_full | A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title_fullStr | A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title_full_unstemmed | A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title_short | A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment |
title_sort | review of functional pancreatic neuroendocrine tumors: exploring the molecular pathogenesis, diagnosis and treatment |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659674/ https://www.ncbi.nlm.nih.gov/pubmed/37986400 http://dx.doi.org/10.1097/MD.0000000000036094 |
work_keys_str_mv | AT alshareefyyasir areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT cumminssinead areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT mazzoleniadele areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT sharmavidushi areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT guggilapusaibaba areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT leongamandawengyee areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT wirekoandrewawuah areviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT alshareefyyasir reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT cumminssinead reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT mazzoleniadele reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT sharmavidushi reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT guggilapusaibaba reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT leongamandawengyee reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment AT wirekoandrewawuah reviewoffunctionalpancreaticneuroendocrinetumorsexploringthemolecularpathogenesisdiagnosisandtreatment |